Junfa Yang

734 total citations
35 papers, 546 citations indexed

About

Junfa Yang is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Junfa Yang has authored 35 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Epidemiology and 12 papers in Cancer Research. Recurrent topics in Junfa Yang's work include Liver Disease Diagnosis and Treatment (11 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (7 papers). Junfa Yang is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), MicroRNA in disease regulation (7 papers) and Circular RNAs in diseases (7 papers). Junfa Yang collaborates with scholars based in China and United States. Junfa Yang's co-authors include Hui Fang, Changyao Li, Tao Xu, Liang‐yun Li, Lingling Zhang, Bangjie Chen, Jun Li, Hong Zhou, Wenjian Chen and Xiao‐Ming Meng and has published in prestigious journals such as Chemical Engineering Journal, The FASEB Journal and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Junfa Yang

33 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junfa Yang China 17 292 204 123 70 58 35 546
Yang Cheng China 14 331 1.1× 206 1.0× 144 1.2× 59 0.8× 44 0.8× 36 606
Quanbao Zhang China 16 252 0.9× 135 0.7× 75 0.6× 87 1.2× 62 1.1× 40 603
Kangkang Yu China 16 331 1.1× 190 0.9× 255 2.1× 161 2.3× 55 0.9× 44 708
Zijing Xia China 16 424 1.5× 242 1.2× 76 0.6× 32 0.5× 83 1.4× 30 754
Yaqiu Zheng China 12 224 0.8× 102 0.5× 82 0.7× 35 0.5× 35 0.6× 21 425
Zhongjie Yi China 11 307 1.1× 143 0.7× 141 1.1× 57 0.8× 28 0.5× 26 589
Hing Lok Wong Hong Kong 9 216 0.7× 136 0.7× 144 1.2× 94 1.3× 63 1.1× 11 682
Claire Renard France 12 374 1.3× 84 0.4× 120 1.0× 118 1.7× 49 0.8× 22 700
Soo Teik Lee South Korea 11 152 0.5× 103 0.5× 62 0.5× 50 0.7× 24 0.4× 21 351
Derrick Zhao United States 11 379 1.3× 176 0.9× 350 2.8× 163 2.3× 80 1.4× 21 727

Countries citing papers authored by Junfa Yang

Since Specialization
Citations

This map shows the geographic impact of Junfa Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfa Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfa Yang more than expected).

Fields of papers citing papers by Junfa Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfa Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfa Yang. The network helps show where Junfa Yang may publish in the future.

Co-authorship network of co-authors of Junfa Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Junfa Yang. A scholar is included among the top collaborators of Junfa Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfa Yang. Junfa Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Junfa, et al.. (2025). Schottky barrier in pea-like Au@Bi2S3 nanoreactor enabling efficient photodynamic therapy of hepatocellular carcinoma. Materials Today Bio. 33. 102001–102001. 3 indexed citations
2.
Yang, Junfa, et al.. (2025). SIRT1 in Liver Diseases: Mechanistic Insights and Therapeutic Prospects. International Journal of Biological Sciences. 21(15). 7086–7103. 1 indexed citations
3.
Yan, Qi, Rong Fan, Qian Cheng, et al.. (2024). NUP85 alleviates lipid metabolism and inflammation by regulating PI3K/AKT signaling pathway in nonalcoholic fatty liver disease. International Journal of Biological Sciences. 20(6). 2219–2235. 16 indexed citations
4.
Yang, Junfa, Yue Su, Yan Yao, et al.. (2024). Research Progress on the Correlation between Acetaldehyde Dehydrogenase 2 and Hepatocellular Carcinoma Development. Journal of Pharmacology and Experimental Therapeutics. 389(2). 163–173. 1 indexed citations
5.
Chen, Bangjie, Tao Jin, Ziyue Fu, et al.. (2023). Non-thermal plasma-treated melatonin inhibits the biological activity of HCC cells by increasing intracellular ROS levels and reducing RRM2 expression. Heliyon. 9(5). e15992–e15992. 6 indexed citations
6.
Yang, Junfa, et al.. (2023). SOX9 promotes the invasion and migration of lung adenocarcinoma cells by activating the RAP1 signaling pathway. BMC Pulmonary Medicine. 23(1). 421–421. 1 indexed citations
7.
Yang, Fan, Jianpeng Wang, Bangjie Chen, et al.. (2022). Role of microRNA alternation in the pathogenesis of gouty arthritis. Frontiers in Endocrinology. 13. 967769–967769. 8 indexed citations
8.
Li, Peng, Shuang Hu, Qian Cheng, et al.. (2021). The Therapeutic Effect of Traditional Chinese Medicine on Inflammatory Diseases Caused by Virus, Especially on Those Caused by COVID-19. Frontiers in Pharmacology. 12. 650425–650425. 7 indexed citations
9.
Hu, Shuang, Xingyu Zhu, Shaowei Jiang, et al.. (2021). The Role of IL-35 in the Pathophysiological Processes of Liver Disease. Frontiers in Pharmacology. 11. 569575–569575. 8 indexed citations
10.
Li, Liang‐yun, Junfa Yang, Shuang Hu, et al.. (2021). ZEB1 serves an oncogenic role in the tumourigenesis of HCC by promoting cell proliferation, migration, and inhibiting apoptosis via Wnt/β-catenin signaling pathway. Acta Pharmacologica Sinica. 42(10). 1676–1689. 28 indexed citations
11.
Yang, Junfa, Changqing Xu, Maomao Wu, et al.. (2021). MicroRNA-124 inhibits hepatic stellate cells inflammatory cytokines secretion by targeting IQGAP1 through NF-κB pathway. International Immunopharmacology. 95. 107520–107520. 20 indexed citations
12.
Yang, Junfa, Maomao Wu, Hui Fang, et al.. (2021). Puerarin Prevents Acute Liver Injury via Inhibiting Inflammatory Responses and ZEB2 Expression. Frontiers in Pharmacology. 12. 727916–727916. 21 indexed citations
13.
Hu, Shuang, Yan Yao, Shuxian Wang, et al.. (2021). Deletion of p38γ attenuates ethanol consumption- and acetaminophen-induced liver injury in mice through promoting Dlg1. Acta Pharmacologica Sinica. 43(7). 1733–1748. 10 indexed citations
14.
Chen, Wenjian, Meng Gu, Bangjie Chen, et al.. (2021). The Prognostic Value and Mechanisms of TMEM16A in Human Cancer. Frontiers in Molecular Biosciences. 8. 542156–542156. 10 indexed citations
15.
Liu, Qingxue, Yiwen Zhou, Junfa Yang, et al.. (2021). Rev-erbα exacerbates hepatic steatosis in alcoholic liver diseases through regulating autophagy. Cell & Bioscience. 11(1). 129–129. 8 indexed citations
16.
Zhou, Huan, Junfa Yang, Chang Sheng Zhou, et al.. (2021). A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV. Frontiers in Medicine. 8. 628370–628370. 45 indexed citations
17.
Xu, Tao, Liang‐yun Li, Shuang Hu, et al.. (2020). MicroRNA‐708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88. Journal of Cellular and Molecular Medicine. 24(13). 7127–7140. 16 indexed citations
18.
Yang, Junfa, Hui Fang, Yuchen Lu, et al.. (2020). Paeonol derivative-6 attenuates inflammation by activating ZEB2 in acute liver injury. International Immunopharmacology. 91. 107235–107235. 11 indexed citations
19.
Li, Liang‐yun, Hong Zhou, Junfa Yang, et al.. (2019). Relevance function of microRNA-708 in the pathogenesis of cancer. Cellular Signalling. 63. 109390–109390. 24 indexed citations
20.
Li, Liang‐yun, Chenchen Yang, Junfa Yang, et al.. (2019). ZEB1 regulates the activation of hepatic stellate cells through Wnt/β-catenin signaling pathway. European Journal of Pharmacology. 865. 172787–172787. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yang Cheng Breakdown of academic impact, for papers by Quanbao Zhang Breakdown of academic impact, for papers by Kangkang Yu Breakdown of academic impact, for papers by Zijing Xia Breakdown of academic impact, for papers by Yaqiu Zheng Breakdown of academic impact, for papers by Zhongjie Yi Breakdown of academic impact, for papers by Hing Lok Wong Breakdown of academic impact, for papers by Claire Renard Breakdown of academic impact, for papers by Soo Teik Lee Breakdown of academic impact, for papers by Derrick Zhao
Rankless by CCL
2026